These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28815430)

  • 1. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.
    Villanueva-Lozano H; Treviño-Rangel RJ; González GM; Hernández-Rodríguez PA; Camacho-Ortiz A; Castillo-Reyna L; Galindo-Alvarado SG; Martínez-Reséndez MF
    Infection; 2018 Feb; 46(1):25-30. PubMed ID: 28815430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
    Rhein J; Huppler Hullsiek K; Tugume L; Nuwagira E; Mpoza E; Evans EE; Kiggundu R; Pastick KA; Ssebambulidde K; Akampurira A; Williams DA; Bangdiwala AS; Abassi M; Musubire AK; Nicol MR; Muzoora C; Meya DB; Boulware DR;
    Lancet Infect Dis; 2019 Aug; 19(8):843-851. PubMed ID: 31345462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Lofgren S; Abassi M; Rhein J; Boulware DR
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
    Jarvis JN; Meintjes G; Rebe K; Williams GN; Bicanic T; Williams A; Schutz C; Bekker LG; Wood R; Harrison TS
    AIDS; 2012 Jun; 26(9):1105-13. PubMed ID: 22421244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
    Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
    Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
    Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR;
    Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.
    Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R
    J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
    Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
    PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays.
    Katchanov J; von Kleist M; Arastéh K; Stocker H
    QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
    Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
    Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.